<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin CC</submitter><funding>NIAID NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>e190215</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12483566</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>135(19)</volume><pubmed_abstract>The cystine-xCT transporter/glutathione/GPX4 axis is the canonical pathway protecting cells from ferroptosis. Whereas GPX4-targeting ferroptosis-inducing compounds (FINs) act independently of mitochondria, xCT-targeting FINs require mitochondrial lipid peroxidation, though the mechanism remains unclear. Because cysteine is also a precursor for coenzyme A (CoA) biosynthesis, here, we demonstrated that CoA supplementation selectively prevented ferroptosis triggered by xCT inhibition by regulating the mitochondrial thioredoxin system. Our data showed that CoA regulated the in vitro enzymatic activity of mitochondrial thioredoxin reductase-2 (TXNRD2) by covalently modifying the thiol group of cysteine (CoAlation) on Cys-483. Replacing Cys-483 with alanine on TXNRD2 abolished its enzymatic acti</pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>Coenzyme A protects against ferroptosis via CoAlation of mitochondrial thioredoxin reductase.</pubmed_title><pmcid>PMC12483566</pmcid><funding_grant_id>R01 GM124062</funding_grant_id><funding_grant_id>R01 NS111588</funding_grant_id><funding_grant_id>R21 AI149205</funding_grant_id><pubmed_authors>Lin YT</pubmed_authors><pubmed_authors>Setayeshpour Y</pubmed_authors><pubmed_authors>Chen SY</pubmed_authors><pubmed_authors>Guruprasad L</pubmed_authors><pubmed_authors>Hayflick SJ</pubmed_authors><pubmed_authors>Lin CC</pubmed_authors><pubmed_authors>Zhang GF</pubmed_authors><pubmed_authors>Nguyen T</pubmed_authors><pubmed_authors>Jeong SY</pubmed_authors><pubmed_authors>Mestre AA</pubmed_authors><pubmed_authors>Gout I</pubmed_authors><pubmed_authors>Banerjee A</pubmed_authors><pubmed_authors>Lin CY</pubmed_authors><pubmed_authors>Chi JT</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Filonenko V</pubmed_authors><pubmed_authors>Soderblom EJ</pubmed_authors><pubmed_authors>Dunn DE</pubmed_authors><pubmed_authors>Floyd SR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Coenzyme A protects against ferroptosis via CoAlation of mitochondrial thioredoxin reductase.</name><description>The cystine-xCT transporter/glutathione/GPX4 axis is the canonical pathway protecting cells from ferroptosis. Whereas GPX4-targeting ferroptosis-inducing compounds (FINs) act independently of mitochondria, xCT-targeting FINs require mitochondrial lipid peroxidation, though the mechanism remains unclear. Because cysteine is also a precursor for coenzyme A (CoA) biosynthesis, here, we demonstrated that CoA supplementation selectively prevented ferroptosis triggered by xCT inhibition by regulating the mitochondrial thioredoxin system. Our data showed that CoA regulated the in vitro enzymatic activity of mitochondrial thioredoxin reductase-2 (TXNRD2) by covalently modifying the thiol group of cysteine (CoAlation) on Cys-483. Replacing Cys-483 with alanine on TXNRD2 abolished its enzymatic acti</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T01:53:41.717Z</modification><creation>2026-05-04T03:14:04.904Z</creation></dates><accession>S-EPMC12483566</accession><cross_references><pubmed>40694424</pubmed><doi>10.1172/JCI190215</doi></cross_references></HashMap>